Abstract
Glaucoma is one of the leading causes of blindness in developed countries and is mainly attributable to the apoptosis of retinal ganglion cells (RGCs). Although several diagnostic tools have been developed to detect and monitor this disease, none has the requisite sensitivity to identify it at a preclinical stage or to perceive small changes in retinal health over short periods. Specifically, irreversible visual changes occur before neuronal damage is discovered. The most widely accepted in vitro assay for apoptotic cells involves the use of fluorescent annexin A5. The radiolabelling of this marker makes it possible to assess, in vivo and non-invasively, various diseases in which the apoptotic process is pivotal, such as myocardial infarction or tumour response to chemotherapy. Recently, a new technique has been developed to visualise directly individual RGCs undergoing apoptosis in the living eye. This DARC (detection of apoptosing retinal cells) technology uses fluorescently labelled annexin A5 to bind apoptosing retinal neurons and confocal scanning laser ophthalmoscopy to detect the marked dying cells. Based on experimental models, DARC has been suggested to offer a direct and quantitative assessment of the retinal condition of patients. A Phase I clinical trial in glaucoma patients is scheduled to start shortly. This technology has the potential to pre-empt the diagnosis of glaucoma prior to visual deterioration, to provide an accurate numeric evaluation highlighting even small retinal changes and to allow the rapid judgement of the efficacy of both current and new therapeutic strategies.
Similar content being viewed by others
References
Ascher MS, Sheppard HW, Krowka JF, Bremermann HJ (1995) AIDS as immune system activation. Key questions that remain. Adv Exp Med Biol 374:203–210
Barr PM, Lazarus HM, Cooper BW, Schluchter MD, Panneerselvam A, Jacobberger JW, Hsu JW, Janakiraman N, Simic A, Dowlati A, Remick SC (2009) Phase II study of bryostatin 1 and vincristine for aggressive non-Hodgkin lymphoma relapsing after an autologous stem cell transplant. Am J Hematol 84:484–487
Baskic D, Popovic S, Ristic P, Arsenijevic NN (2006) Analysis of cycloheximide-induced apoptosis in human leukocytes: fluorescence microscopy using annexin V/propidium iodide versus acridin orange/ethidium bromide. Cell Biol Int 30:924–932
Belhocine T, Steinmetz N, Hustinx R, Bartsch P, Jerusalem G, Seidel L, Rigo P, Green A (2002) Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. Clin Cancer Res 8:2766–2774
Bennett TJ, Barry CJ (2009) Ophthalmic imaging today: an ophthalmic photographer’s viewpoint—a review. Clin Exp Ophthalmol 37:2–13
Blankenberg FG, Katsikis PD, Tait JF, Davis RE, Naumovski L, Ohtsuki K, Kopiwoda S, Abrams MJ, Darkes M, Robbins RC, Maecker HT, Strauss HW (1998) In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci USA 95:6349–6354
Boersma HH, Liem IH, Kemerink GJ, Thimister PW, Hofstra L, Stolk LM, van Heerde WL, Pakbiers MT, Janssen D, Beysens AJ, Reutelingsperger CP, Heidendal GA (2003) Comparison between human pharmacokinetics and imaging properties of two conjugation methods for 99mTc-annexin A5. Br J Radiol 76:553–560
Campian ME, Tan HL, van Moerkerken AF, Tukkie R, van Eck-Smit BL, Verberne HJ (2011) Imaging of programmed cell death in arrhythmogenic right ventricle cardiomyopathy/dysplasia. Eur J Nucl Med Mol Imaging 38:1500–1506
Carroll AD, Moyen C, Van Kesteren P, Tooke F, Battey NH, Brownlee C (1998) Ca2+, annexins, and GTP modulate exocytosis from maize root cap protoplasts. Plant Cell 10:1267–1276
Chang EE, Goldberg JL (2012) Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement. Ophthalmology 119:979–986
Cordeiro MF, Guo L, Luong V, Harding G, Wang W, Jones HE, Moss SE, Sillito AM, Fitzke FW (2004) Real-time imaging of single nerve cell apoptosis in retinal neurodegeneration. Proc Natl Acad Sci USA 101:13352–13356
Cordeiro MF, Guo L, Coxon KM, Duggan J, Nizari S, Normando EM, Sensi SL, Sillito AM, Fitzke FW, Salt TE, Moss SE (2010) Imaging multiple phases of neurodegeneration: a novel approach to assessing cell death in vivo. Cell Death Dis 1:e3
Cordeiro MF, Migdal C, Bloom P, Fitzke FW, Moss SE (2011) Imaging apoptosis in the eye. Eye (Lond) 25:545–553
Cullinan AE, Brandt CR (2004) Cytokine induced apoptosis in human retinoblastoma cells. Mol Vis 10:315–322
Dumont EA, Reutelingsperger CP, Smits JF, Daemen MJ, Doevendans PA, Wellens HJ, Hofstra L (2001) Real-time imaging of apoptotic cell-membrane changes at the single-cell level in the beating murine heart. Nat Med 7:1352–1355
Festoff BW (1996) Amyotrophic lateral sclerosis: current and future treatment strategies. Drugs 51:28–44
García-Santos G, Antolín I, Herrera F, Martín V, Rodriguez-Blanco J, del Pilar Carrera M, Rodriguez C (2006) Melatonin induces apoptosis in human neuroblastoma cancer cells. J Pineal Res 41:130–135
Garcia-Valenzuela E, Shareef S, Walsh J, Sharma SC (1995) Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp Eye Res 61:33–44
Gohdes DM, Balamurugan A, Larsen BA, Maylahn C (2005) Age-related eye diseases: an emerging challenge for public health professionals. Prev Chronic Dis 2:A17
Gschwind M, Huber G (1995) Apoptotic cell death induced by beta-amyloid 1–42 peptide is cell type dependent. J Neurochem 65:292–300
Guo L, Moss SE, Alexander RA, Ali RR, Fitzke FW, Cordeiro MF (2005) Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix. Invest Ophthalmol Vis Sci 46:175–182
Guo L, Salt TE, Maass A, Luong V, Moss SE, Fitzke FW, Cordeiro MF (2006) Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo. Invest Ophthalmol Vis Sci 47:626–633
Guo L, Salt TE, Luong V, Wood N, Cheung W, Maass A, Ferrari G, Russo-Marie F, Sillito AM, Cheetham ME, Moss SE, Fitzke FW, Cordeiro MF (2007) Targeting amyloid-beta in glaucoma treatment. Proc Natl Acad Sci USA 104:13444–13449
Harwerth RS, Wheat JL, Rangaswamy NV (2008) Age-related losses of retinal ganglion cells and axons. Invest Ophthalmol Vis Sci 49(10):4437–4443
Hoebers FJ, Kartachova M, de Bois J, van den Brekel MW, van Tinteren H, van Herk M, Rasch CR, Valdes Olmos RA, Verheij M (2008) 99mTc Hynic-rh-Annexin V scintigraphy for in vivo imaging of apoptosis in patients with head and neck cancer treated with chemoradiotherapy. Eur J Nucl Med Mol Imaging 35:509–518
Hofstra L, Liem IH, Dumont EA, Boersma HH, van Heerde WL, Doevendans PA, De Muinck E, Wellens HJ, Kemerink GJ, Reutelingsperger CP, Heidendal GA (2000) Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet 356:209–212
Hofstra L, Dumont EA, Thimister PW, Heidendal GA, DeBruine AP, Elenbaas TW, Boersma HH, van Heerde WL, Reutelingsperger CP (2001) In vivo detection of apoptosis in an intracardiac tumor. JAMA 285:1841–1842
Horisberger K, Erben P, Strobel P, Bohn B, Hahn M, Kahler G, Wenz F, Hochhaus A, Post S, Willeke F, Hofheinz RD (2010) Annexin and survivin in locally advanced rectal cancer: indicators of resistance to preoperative chemoradiotherapy? Onkologie 33:439–444
Jakobs TC, Libby RT, Ben Y, John SW, Masland RH (2005) Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice. J Cell Biol 171:313–325
Jonas JB, Schmidt AM, Muller-Bergh JA, Schlotzer-Schrehardt UM, Naumman GO (1992) Human optic nerve fiber count and optic disc size. Invest Ophthalmol Vis Sci 33(6):2012–2018
Kartachova M, Haas RL, Olmos RA, Hoebers FJ, van Zandwijk N, Verheij M (2004) In vivo imaging of apoptosis by 99mTc-Annexin V scintigraphy: visual analysis in relation to treatment response. Radiother Oncol 72:333–339
Kartachova MS, Valdes Olmos RA, Haas RL, Hoebers FJ, van den Brekel MW, van Zandwijk N, Herk M, Verheij M (2006) Mapping of treatment-induced apoptosis in normal structures: 99mTc-Hynic-rh-annexin V SPECT and CT image fusion. Eur J Nucl Med Mol Imaging 33:893–899
Kartachova M, van Zandwijk N, Burgers S, van Tinteren H, Verheij M, Valdes Olmos RA (2007) Prognostic significance of 99mTc Hynic-rh-annexin V scintigraphy during platinum-based chemotherapy in advanced lung cancer. J Clin Oncol 25:2534–2539
Kerrigan-Baumrind LA, Quigley HA, Pease ME, Kerrigan DF, Mitchell RS (2000) Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Invest Ophthalmol Vis Sci 41:741–748
Kurihara H, Yang DJ, Cristofanilli M, Erwin WD, Yu DF, Kohanim S, Mendez R, Kim EE (2008) Imaging and dosimetry of 99mTc EC annexin V: preliminary clinical study targeting apoptosis in breast tumors. Appl Radiat Isot 66:1175–1182
Lahorte CM, van de Wiele C, Bacher K, van den Bossche B, Thierens H, van Belle S, Slegers G, Dierckx RA (2003) Biodistribution and dosimetry study of 123I-rh-annexin V in mice and humans. Nucl Med Commun 24:871–880
Lampl Y, Lorberboym M, Blankenberg FG, Sadeh M, Gilad R (2006) Annexin V SPECT imaging of phosphatidylserine expression in patients with dementia. Neurology 66:1253–1254
Margolin K, Synold TW, Lara P, Frankel P, Lacey SF, Quinn DI, Baratta T, Dutcher JP, Xi B, Diamond DJ, Gandara DR (2007) Oblimersen and alpha-interferon in metastatic renal cancer: a phase II study of the California Cancer Consortium. J Cancer Res Clin Oncol 133:705–711
Narula J, Acio ER, Narula N, Samuels LE, Fyfe B, Wood D, Fitzpatrick JM, Raghunath PN, Tomaszewski JE, Kelly C, Steinmetz N, Green A, Tait JF, Leppo J, Blankenberg FG, Jain D, Strauss HW (2001) Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nat Med 7:1347–1352
Nickells RW (1999) Apoptosis of retinal ganglion cells in glaucoma: an update of the molecular pathways involved in cell death. Surv Ophthalmol 43 (Suppl 1):S151–S161
Niu G, Chen X (2010) Apoptosis imaging: beyond annexin V. J Nucl Med 51:1659–1662
Pollard H, Cantagrel S, Charriaut-Marlangue C, Moreau J, Ben Ari Y (1994) Apoptosis associated DNA fragmentation in epileptic brain damage. Neuroreport 5:1053–1055
Portera-Cailliau C, Sung CH, Nathans J, Adler R (1994) Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa. Proc Natl Acad Sci USA 91:974–978
Prokofyeva E, Zrenner E (2012) Epidemiology of major eye diseases leading to blindness in Europe: a literature review. Ophthalmic Res 47:171–188
Qu J, Wang D, Grosskreutz CL (2010) Mechanisms of retinal ganglion cell injury and defense in glaucoma. Exp Eye Res 91:48–53
Quigley HA (1995) Ganglion cell death in glaucoma: pathology recapitulates ontogeny. Aust N Z J Ophthalmol 23:85–91
Quigley HA (1996) Number of people with glaucoma worldwide. Br J Ophthalmol 80:389–393
Quigley HA (2011) Glaucoma. Lancet 377:1367–1377
Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ (1995) Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci 36:774–786
Quigley HA, Park CK, Tracey PA, Pollack IP (2002) Community screening for eye disease by laypersons: the Hoffberger program. Am J Ophthalmol 133:386–392
Quinn R (2005) Comparing rat’s to human’s age: how old is my rat in people years? Nutrition 21:775–777
Raynal P, Pollard HB (1994) Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim Biophys Acta 1197:63–93
Raza A, Mundle S, Iftikhar A, Gregory S, Marcus B, Khan Z, Alvi S, Shetty V, Dameron S, Wright V et al (1995) Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis. Am J Hematol 48:143–154
Rebello G, Ramesar R, Vorster A, Roberts L, Ehrenreich L, Oppon E, Gama D, Bardien S, Greenberg J, Bonapace G, Waheed A, Shah GN, Sly WS (2004) Apoptosis-inducing signal sequence mutation in carbonic anhydrase IV identified in patients with the RP17 form of retinitis pigmentosa. Proc Natl Acad Sci USA 101:6617–6622
Reichstein D, Ren L, Filippopoulos T, Mittag T, Danias J (2007) Apoptotic retinal ganglion cell death in the DBA/2 mouse model of glaucoma. Exp Eye Res 84:13–21
Reme CE, Grimm C, Hafezi F, Marti A, Wenzel A (1998) Apoptotic cell death in retinal degenerations. Prog Retin Eye Res 17:443–464
Sample PA, Johnson CA (2001) Functional assessment of glaucoma. J Glaucoma 10:S49–S52
Schmitz-Valckenberg S, Guo L, Maass A, Cheung W, Vugler A, Moss SE, Munro PM, Fitzke FW, Cordeiro MF (2008) Real-time in vivo imaging of retinal cell apoptosis after laser exposure. Invest Ophthalmol Vis Sci 49:2773–2780
Schuettauf F, Rejdak R, Walski M, Frontczak-Baniewicz M, Voelker M, Blatsios G, Shinoda K, Zagorski Z, Zrenner E, Grieb P (2004) Retinal neurodegeneration in the DBA/2J mouse—a model for ocular hypertension. Acta Neuropathol 107:352–358
Selleri C, Maciejewski JP, Sato T, Young NS (1996) Interferon-gamma constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition. Blood 87:4149–4157
Shimizu A, Yamanaka N (1993) Apoptosis and cell desquamation in repair process of ischemic tubular necrosis. Virchows Archiv [B] 64:171–180
Sihota R (2011) Classification of primary angle closure disease. Curr Opin Ophthalmol 22:87–95
Sommer A (1989) Intraocular pressure and glaucoma. Am J Ophthalmol 107:186–188
Stratton JR, Dewhurst TA, Kasina S, Reno JM, Cerqueira MD, Baskin DG, Tait JF (1995) Selective uptake of radiolabeled annexin V on acute porcine left atrial thrombi. Circulation 92:3113–3121
Su D, Park SC, Simonson JL, Liebmann JM, Ritch R (2012) Progression pattern of initial parafoveal scotomas in glaucoma. Ophthalmology 2012 pii:S0161-6420(12)00789-0
Tatton NA, Tezel G, Insolia SA, Nandor SA, Edward PD, Wax MB (2001) In situ detection of apoptosis in normal pressure glaucoma. A preliminary examination. Surv Ophthalmol 45 (Suppl 3):S268–S272
Thimister PW, Hofstra L, Liem IH, Boersma HH, Kemerink G, Reutelingsperger CP, Heidendal GA (2003) In vivo detection of cell death in the area at risk in acute myocardial infarction. J Nucl Med 44:391–396
Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267:1456–1462
Thuret G, Chiquet C, Herrag S, Dumollard JM, Boudard D, Bednarz J, Campos L, Gain P (2003) Mechanisms of staurosporine induced apoptosis in a human corneal endothelial cell line. Br J Ophthalmol 87:346–352
van de Wiele C, Lahorte C, Vermeersch H, Loose D, Mervillie K, Steinmetz ND, Vanderheyden JL, Cuvelier CA, Slegers G, Dierck RA (2003) Quantitative tumor apoptosis imaging using technetium-99m-HYNIC annexin V single photon emission computed tomography. J Clin Oncol 21:3483–3487
van Engeland M, Nieland LJ, Ramaekers FC, Schutte B, Reutelingsperger CP (1998) Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31:1–9
Vermeersch H, Ham H, Rottey S, Lahorte C, Corsetti F, Dierckx R, Steinmetz N, van de Wiele C (2004a) Intraobserver, interobserver, and day-to-day reproducibility of quantitative 99mTc-HYNIC annexin-V imaging in head and neck carcinoma. Cancer Biother Radiopharm 19:205–210
Vermeersch H, Loose D, Lahorte C, Mervillie K, Dierckx R, Steinmetz N, Vanderheyden JL, Cuvelier C, Slegers G, van de Wiele C (2004b) 99mTc-HYNIC Annexin-V imaging of primary head and neck carcinoma. Nucl Med Commun 25:259–263
Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C (1995) A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 184:39–51
Walkinshaw G, Waters CM (1995) Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson’s disease. J Clin Invest 95:2458–2464
Zeyen T (1999) Target pressures in glaucoma. Bull Soc Belge Ophtalmol 274:61–65
Conflict of interest
M. Francesca Cordeiro has submitted a patent application concerning DARC technology.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Normando, E.M., Turner, L.A. & Cordeiro, M.F. The potential of annexin-labelling for the diagnosis and follow-up of glaucoma. Cell Tissue Res 353, 279–285 (2013). https://doi.org/10.1007/s00441-013-1554-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00441-013-1554-5